Suchergebnisse - "Billot, Laurent"

PubPharm (7)

1

Sodium chloride or Plasmalyte-148 evaluation in severe diabetic ketoacidosis (SCOPE-DKA) : a cluster, crossover, randomized, controlled trial

enthalten in: Intensive care medicine | 2021

von Ramanan, M. | Attokaran, A. | Murray, L. | +28

CommentIn: Intensive Care Med. 2021 Nov;47(11):1312-1314. - PMID 34608527

2

Sodium chloride or Plasmalyte-148 evaluation in severe diabetic ketoacidosis (SCOPE-DKA): a cluster, crossover, randomized, controlled trial

enthalten in: Intensive care medicine | 2021

von Ramanan, M. | Attokaran, A. | Murray, L. | +10

3

Sodium chloride or Plasmalyte-148 evaluation in severe diabetic ketoacidosis (SCOPE-DKA): a cluster, crossover, randomized, controlled trial

enthalten in: Intensive care medicine | 2021

von Ramanan, M. | Attokaran, A. | Murray, L. | +10

4

Sodium chloride or Plasmalyte-148 evaluation in severe diabetic ketoacidosis (SCOPE-DKA): a cluster, crossover, randomized, controlled trial

enthalten in: Intensive care medicine | 2021

von Ramanan, M. | Attokaran, A. | Murray, L. | +10

5

Fluid resuscitation with 6 % hydroxyethyl starch (130/0.4 and 130/0.42) in acutely ill patients: systematic review of effects on mortality and treatment with renal replacement therapy

enthalten in: Intensive care medicine | 2013

von Gattas, D. | Dan, A. | Myburgh, J. | +3

6

Fluid resuscitation with 6 % hydroxyethyl starch (130/0.4 and 130/0.42) in acutely ill patients: systematic review of effects on mortality and treatment with renal replacement therapy

enthalten in: Intensive care medicine | 2013

von Gattas, D. | Dan, A. | Myburgh, J. | +3

7

Fluid resuscitation with 6 % hydroxyethyl starch (130/0.4 and 130/0.42) in acutely ill patients: systematic review of effects on mortality and treatment with renal replacement therapy

enthalten in: Intensive care medicine | 2013

von Gattas, D. | Dan, A. | Myburgh, J. | +3

1
[1]